Allied Market Research
Loading...
0
Allied Market Research

Skin Cancer Diagnostics and Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

A10368
Pages: NA
Aug 2021 | 306 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Skin Cancer Diagnostics and Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Request Now !

Skin Cancer Diagnostics and Therapeutics Market Outlook - 2027

Skin cancer means an abnormal growth of skin cells. It develops in those areas that are exposed to the sun. Skin cancer is the most common form of cancer. There are two main categories of skin cancer such as melanoma and non melanoma.  Nonmelanoma skin cancer may appear as a firm red nodule, a scaly growth that develops a coating which does not heal. It is mostly occur on nose, forehead, ears, lower lip, and hands. To diagnose skin cancer various types of imaging solution such as CT scan, MRI, PET scan, bone scan, and chest X-ray. The ultraviolet radiation changes the genetic material (DNA) in cells and is, therefore, the main cause of skin cancer.  The skin cancer diagnostics and therapeutics market include various diagnostics and therapies associated to skin cancer such as chemotherapy, targeted therapy, immunotherapy, radiotherapy, freezing therapy, and scraping therapy which help to cure skin cancer. The various preventable risk factors of this disease consist of exposed to sunlight, sunlamps and tanning. “American Cancer Society, state that exposure to the sun is the most preventable risk factor for all skin cancers. “Federal Centers for Disease Control and Prevention” (CDC), state that the rate of new melanoma cases among both men and women has been increasing at 1.7% and 1.4% per year.

Skin-Cancer-Diagnostics-and-Therapeutics-Market

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2020–2027

  Base year considered

  2019

  Forecast period

  2021–2027

  Forecast units

  Value ($USD)

  Segments covered

  Type, Therapy, Diagnoses, End User

  Region covered

North America (U.S., and Canada), Europe (U.K, France, Italy, Russia, Turkey, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia Thailand, Indonesia and Rest of Asia-Pacific), LANTAM (Brazil, and Rest of Latin America), Middle East & Africa (GCC and Egypt)

  Companies covered

Major players analyzed include, Agilent, Amgen, Aqua Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Elekta, Eli Lilly, Roche, GSK, iCAD, Bausch Health, Merck & Co., Novartis, Pfizer, QIAGEN, Sanofi, Teva Pharmaceutical, Varian Medical Systems.

 

COVID-19 Scenario Analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

 The ongoing outbreak of COVID-19 pandemic impacted the pharmaceutical industry positively. It affect skin cancer diagnostics and therapeutics market. According to the ASCO, during this situation they state that hold the treatment for cancer associate disease if the patient have affected with coronavirus because it is life threatening for the health condition of cancer patient. They also state that if the patient associated with cancer but do not have infected with coronavirus, cancer treatment is available. But due to the government announced lockdown in various region people not getting proper treatment. This affect the major end user of the market such hospital they losses their business and major market player as well.  

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America hold the largest market share and dominate overall market due to the increasing prevalence of melanoma and other skin cancers, presence of well-developed hospital facilities, availability of large number of advanced product and therapy for skin cancer. However, Asia Pacific expand skin cancer diagnosis and therapeutic market growth rate due to rapidly increasing prevalence of skin cancer, rising demand for low cost of therapeutics, increasing large number of clinical research organizations. 

In 2013, Government of India has approved establishment of “State Cancer Institutes and Tertiary Care Cancer Centers” in India, which is expected to develop the growth of market to a certain extent. In 2017, stated that American Cancer Society, around 87,100 affected with skin cancer. These factor rises the need for drugs that help in preventing melanoma over the coming years.

In 2018, The U.S. government has developed reimbursement policies for treatment of cancer associated with diseases. American Academy of Dermatology, state that around 9,500 people in the United States are diagnosed with skin cancer every day. Skin cancer is the most common cancer in the United States. Most cases of melanoma, the deadliest kind of skin cancer, are caused by exposure to ultraviolet (UV) light. As per the report of ASCO (American Society of Clinical Oncology), more than 3 million people in the United States are diagnosed with non-melanoma skin cancer each year. Basal cell carcinoma is far more common than squamous cell carcinoma. About 80% of non-melanoma skin cancer is basal cell carcinoma.

The factor such as rising government initiatives for improving health care facilities, growing incidences of skin cancer, increasing advancements of skin cancer therapy such as photodynamic therapy (PDT), have been widely used in treating non-melanoma skin malignancies, extension of current therapies are driving the global market for skin cancer diagnostics and therapeutics are drive the growth of skin cancer diagnostics and therapeutics market. The factors such as, high cost of skin cancer treatment, stringent government regulation and lack of awareness about the advanced treatment for cancer associated disease are restraining the growth of skin cancer diagnostics and therapeutics market. The opportunities’ available for the market such as increasing development of cancer associated product, increasing research and development activities, rapidly, increasing skin cancer associated disease rising awareness amongst the people about various advanced therapy for types of cancer and providing cost effective treatment.  

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on increasing research and development activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2017 “Pfizer Inc.” and “Merck KGaA.”, received U.S.FDA approval for the development of formulation such as “BAVENCIO® (AVELUMAB)”, which is an Injection for the treatment of patients with locally advanced or metastatic urothelial carcinoma. In 2018, “AstraZeneca” has launched new test such as “cobas® EGFR Mutation Test v2”. It is a real-time PCR test which identifies 42 specimens. This specimen are processed using the cobas® DNA sample preparation kit and plasma. This test is specified as a companion diagnostic to inhibit the resistant of non small-cell lung cancer.

 In 2019, “Agilent” received the U.S.FDA approval for “Dako PD-L1 IHC 28-8 pharmDx”. It is a qualitative immunohistochemically assay using Monoclonal Rabbit Anti-PD-L1, Clone 28-8 intended for use in the detection of PD-L1 protein in formalin-fixed, paraffin-embedded (FFPE) non-squamous non-small cell lung cancer (NSCLC) tissue using EnVision FLEX visualization system on Autostainer. It is the test for skin cancer patients. In 2019, “Amgen” received FDA Approval for “IMLYGIC™” (Alipogene Laherparepvec). It is the first clinical and regulatory validation of an oncolytic virus as a therapy, which treat the patients with a serious form of skin cancer.

Key segments covered:

Segments

Sub-segments

  Type

  • Actinic Keratoses (Ak)
  • Based Cell Carcinoma (Bcc)
  • Squamous Cell Carcinoma (Scc)
  • Melanoma

  Therapy

  • Chemotherapy
  •  Targeted Therapy
  •  Immunotherapy
  • Radiotherapy
  • Freezing
  • Scraping
  •  Others

  Diagnosis

  • CT-Scan
  • X-Rays
  •  Dermatoscopy
  • Sentinel Lymph Node Biopsy
  •  Blood Test
  • Others

  End User

  • Hospitals
  • Cancer Research Centers
  • Clinics

 

Key benefits of the report:

  • This study presents the analytical depiction of the global skin cancer diagnostics and therapeutics market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global skin cancer diagnostics and therapeutics market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global skin cancer diagnostics and therapeutics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global skin cancer diagnostics and therapeutics market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Skin Cancer Diagnostics and Therapeutics Market research report:

  • Who are the leading market players active in skin cancer diagnostics and therapeutics market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Skin Cancer Diagnostics and Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers